The UK is investing millions of pounds into a human SARS-CoV-2 challenge study in which healthy volunteers will be given the virus in the hopes of better understanding infections and accelerating vaccine development, according to Reuters.
The UK is investing millions of pounds into a human SARS-CoV-2 challenge study in which healthy volunteers will be given the virus in the hopes of better understanding infections and accelerating vaccine development, according to Reuters.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.